King Pharmaceuticals will cut 20% of its 2,600 employee workforce after a federal appeals court judge ruled against a patent extension on the company's blood pressure treatment Altace.

Pfizer chairman Jeff Kindler said during last weeks Bear Stearns Healthcare Conference that the company expects Lipitor sales to be flat or down up to 5% on last years numbers due to competition from generic Zocor (simvastatin).

Pfizer will look to re-submit corrections to its US Lipitor patent after the US Patent and Trademark Office rebuffed an initial attempt.

Accusations by AIDS advocates regarding the policies of Indian drugmaker Cipla have led to a full-on dust-up between the two.

The second-quarter earnings parade today told a story of two companies, whose lipid franchises are heading in divergent directions.

Barr Pharmaceuticals said its subsidiary Barr Laboratories received FDA approval for its application to manufacture and market a generic version of Pharmacia and Upjohns Dostinex (cabergoline) tablets, 0.5 mg.

Pfizer has settled its lawsuit against Novartis for alleged infringement of the US patent for the antibiotic Zithromax (azithromycin), Bloomberg News reports.

The FDA today approved the first generic versions of Novartis Lamisil (terbinafine hydrochloride) tablets, used to treat nail fungus infection (onychomycosis).

A federal judges decision yesterday to uphold the patent on blood thinner Plavix has revived speculation that the drugs co-marketers could join forces. Analysts, however, cast doubt on the idea that Bristol-Myers Squibb would merge with its larger partner Sanofi-Aventis.

Novartis is planning an immediate US launch of generic Lotrel after a federal judge declined to stop a rival’s copies from entering the market.